Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma

NORBERT NECKEL, MARCO MICHAEL, DANIEL TROELTZSCH, JONAS WÜSTER, STEFFEN KOERDT, CHRISTIAN DOLL, KORINNA JÖHRENS, KONRAD NEUMANN, MAX HEILAND and JAN-DIRK RAGUSE
Anticancer Research December 2020, 40 (12) 6987-6995; DOI: https://doi.org/10.21873/anticanres.14723
NORBERT NECKEL
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: norbert.neckel@charite.de
MARCO MICHAEL
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL TROELTZSCH
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JONAS WÜSTER
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFFEN KOERDT
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN DOLL
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KORINNA JÖHRENS
2Institute of Pathology, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KONRAD NEUMANN
3Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAX HEILAND
1Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN-DIRK RAGUSE
4Department of Oral and Maxillofacial Surgery, Fachklinik Hornheide, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The current literature conjectures that oral squamous cell carcinoma (OSCC) in younger patients is an entirely separate entity with a different risk profile. We aimed to uncover the potential risk factors of OSCC and evaluated the long-term outcome in such patients. Patients and Methods: This hospital-based case–control study included 40 patients with OSCC and 40 controls under the age of 46 years. Survival was analyzed via Kaplan–Meier estimates, including a follow-up of up to 24.3 years. Results: The patients with OSCC were prone to smoking and drinking heavily and even suffered secondary organ damage to the lungs and the liver at this young age. Early diagnosed as well as surgically treated patients had superior 5-year recurrence-free and overall survival. Conclusion: Young patients with OSCC were found to have a traditional risk profile. Secondary organ damage to the liver and the lungs might be considered as a risk indicator. The meticulous screening of every age group with this risk profile is key to early diagnosis and acceptable treatment results.

Key Words:
  • Oral squamous cell carcinoma
  • OSCC
  • risk factors
  • young adults
  • case-control study
  • survival analysis
  • smoking
  • alcohol consumption

While most studies addressing risk factors in patients with head and neck squamous cell carcinoma (HNSCC) recently have tended to focus on human papillomavirus (HPV), patients with HNSCC and especially those with oral squamous cell carcinoma (OSCC) still consist mostly of older male individuals with habits of heavy alcohol and tobacco consumption (1-4).

In these cases, the most typical mechanism of carcinogenesis remains field cancerization, including the involvement of macroscopically normal tissue, caused by exposure to harmful substances, thus leading to multi-step tumorigenesis and progression over an extended period. This has also been shown to exist on a molecular level (5-7).

Consequently, because of the characteristic risk factors of drinking and smoking, OSCC is generally considered a preventable disease (8). Over the past decades, a significant number of studies have been carried out which surprisingly demonstrated an increase in OSCC in young adults worldwide (3, 9-11). Younger adults without typical risk factors seem to be affected, which is emotionally distressing for the patients, their families, and healthcare professionals. Mostly, the term ‘young’ is defined as being under 40 or 45 years old (3, 12). This finding surprisingly coincided with a decrease in the aforementioned classic risk factors and led several authors to conclude that HNSCC in a younger population can or should be seen as an entirely different entity (3, 7, 12-16). The frequent lack of traditional risk factors such as alcohol and tobacco consumption in a population under 30 years old was already described in 1975 by Byers for SCCs of the tongue (17). This observation was also made by Kuriakose et al., who reported an association of OSCC with the female gender and fewer risk factors in younger adults (18). This finding was again confirmed by Harris et al., who found that nonsmokers and nondrinkers in a more heterogeneous group with HNSCC are more likely to be younger and predominantly female in contrast to their alcohol- and tobacco-consuming counterparts (16). In the wake of this, a wide variety of other co- or alternative risk factors such as HPV status, nutrition, genetic alterations, long-term irritation, immunosuppression, hormonal status, and other comorbidities are being discussed, but none have been proven to play a superior role in the development of HNSCC or OSCC (3, 6, 7, 12, 14, 19-21).

However, the role of classic risk factors for HNSCC in younger patients and the impact of other parameters have been discussed controversially in the literature, especially since some studies failed to demonstrate significant differences between OSCC in older and younger patients (22, 23). While minor molecular differences are likely to exist, the data are still too sparse to draw definitive conclusions (24). Another major problem in defining risk factors for OSCC arises from its inclusion in the heterogeneous group of HNSCC and a lack of adequate subcategorization (7, 19, 25-27). HPV-positive as well as HPV-negative SCCs, for instance, tend to originate from different tissues and therefore favor distinct locations (12, 28). The former, for example, are associated with lymphoepithelial tissue, such as the base of the tongue and the pharynx, whereas HPV seems not to be typical in OSCC (12, 26). This emphasizes the need for anatomically focused risk assessment studies.

The remaining uncertainties and occasional cases of fatal and emotionally burdening courses in young patients, which cannot be explained sufficiently with the current knowledge, led to the conduction of this investigation. The aim of this study was to evaluate relevant risk factors in younger patients with OSCC and evaluate long-term survival in this patient cohort.

Patients and Methods

This study was approved by the Ethics Committee of the Charité-Universitätsmedizin Berlin, Germany (EA2/107/19).

Of the 590 patients with OSCC treated at the Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, from 1993 to 2006, all those under the age of 46 years were selected. Their medical history was analyzed retrospectively regarding tumor localization, histological diagnosis, classification according to tumor size, node status, and metastasis (TNM), survival, recurrence, and risk factors. Comorbidities such as cardiovascular, pulmonary, or liver diseases as well as diabetes mellitus, immunodeficiency, and allergies were documented. A family history of malignant tumors was also taken into account. The following exogenous factors were considered: History of smoking, drug and alcohol consumption, and poor oral hygiene. The control group was matched by age and gender and selected out of a patient population of 2006 that was hospitalized with diagnoses not related to malignancies. Treatment decisions were made on an interdisciplinary basis after clinical and radiological staging was performed and after histological confirmations of OSCC diagnoses were made. The following parameters were defined to alleviate comparability between the test and control groups.

The body mass index (BMI) was used to define the nutritional level of the patients according to the definition of the World Health Organization (29). The follow-up period for survival analysis lasted until December 2018. As the tumor location was defined according to the anatomical origin, overlapping areas in certain patients were included. Histological analysis was performed by the Department of Pathology of the Charité – Universitätsmedizin Berlin. The tumors were classified according to the fifth edition of the TNM Atlas of the Union Internationale Contre le Cancer (30). Cancer recurrence was screened until January 31, 2013, whereas overall survival (OS) was traced until December 7, 2018. Patients without signs of recurrence until that date were defined as free of recurrence. Based on the parameters defined by the World Health Organization, which were applied to the German federal health study of 2006, smokers were divided into ‘heavy’ smokers (20 or more cigarettes per day), ‘moderate’ smokers (11-20 cigarettes per day), and ‘light’ smokers (less than 10 cigarettes per day) (31). Grouping according to pack-years was impossible because of insufficient documentation and the retrospective character of the study.

To define alcohol consumption, a modified and simplified classification described by Baker et al. was used (32). The definition comprised ‘daily or almost daily/very frequent’ consumption (5 times per week or more), ‘moderately frequent’ consumption (no more than 4 times per week), and abstinence (no alcohol consumption). Further, alcohol consumption was subcategorized into the consumption of beverages with high alcohol concentration (15% or more), moderate concentration (5-15%), and low concentration (5%). Alcoholism was defined as the consumption of at least 60 g alcohol per day in males and 40 g per day in females or was included as such in the case of the documented psychiatric diagnosis (33). The combination of alcohol and tobacco was also taken into consideration.

Socioeconomic status had to be defined retrospectively. Patients with academic professions that required a university or college degree were defined as having high socioeconomic status, whereas patients who worked in professions that necessitated the equivalent of a high-school certificate were defined as having medium socioeconomic status. Those with professions requiring basic or lesser school education were defined as having low socioeconomic status. Unemployed patients were categorized in a separate group. In some cases, a retrospective definition of socioeconomic status was not possible.

In 17 cases, p16 status as a surrogate parameter for HPV was analyzed retrospectively since this was not a standard procedure at the time. All statistical analyses were performed using IBM SPSS Statistics, version 26 (IBM, Armonk, NY, USA). The descriptive analysis of the categorical variables was carried out via frequency count and cross-tabulation. Associations among the categorical variables were examined using Pearson’s chi-square test. Overall and recurrence-free survival were described by Kaplan–Meier curves. For comparisons of the Kaplan–Meier curves, the log-rank test was used. From these curves, 5-year survival rates with two-sided 95% confidence intervals were derived. In this exploratory study, no level of significance was specified, and all the p-values are exploratory.

Results

This study comprised 40 cases suffering OSCC under the age of 46 and their controls, which had been matched according to age and sex. The general characteristics are summarized in Table I. The mean age was 41.5 years, ranging from 27 to 45 years, in the cases and 41 years, ranging from 23 to 45 years, in the controls. The case group consisted of 30 males and 10 females, whereas the control group comprised 28 males and 12 females. The mean age when diagnosed with OSCC was 42.5 years in males and 39 years in females. The BMI was equally distributed in the cases and controls, but the case group comprised more underweight (n=5, 12.5%) and obese (n=5, 12.5%) patients compared to the control group (n=1, 3.8%, and n=1, 3.8%, respectively). Of the 10 females in the case group, seven were smokers, of whom six consumed more than 20 cigarettes per day; 21 out of the 26 male smokers in this group showed the same behavior. None of the smokers in the case group consumed 10 cigarettes per day or less. In the control group, five female and six male patients consumed up to 10 cigarettes per day, nine males and three females consumed up to 20 cigarettes per day, and six males but no females consumed more than 20 cigarettes per day.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Synopsis of general characteristics of cases and controls.

The characteristics of the case group are summarized in Table II, including location, tumor size, and nodal status. The majority of carcinomas were staged as T4 when initially diagnosed, and 57.5% were classified as stage IV tumors according to the Union for International Cancer Control (30). In addition, 70% of all tumors were staged as grade 2; 45% were diagnosed with N0 and 40% with N2 status. Lastly, 31 out of 33 smokers in the OSCC group continued smoking after their initial cancer diagnosis.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Distribution of tumor-specific characteristics in the case group (n=40).

In 17 cases, HPV status (p16 surrogate marker) was analyzed retrospectively, of which one case showed HPV positivity. Around 41% of the cases suffered from cancer recurrence or secondary metastases within the first 5 years after diagnosis, all of which occurred in the first 3 years. The 5-year recurrence-free survival was 67% for tumor stages I and II [95% confidence intervaI (CI)=40.6-85.4%3 and 24% (95% CI=11.2-44.2%) for stages III and IV. When comparing patients who had received surgical therapy with those who had not, 5-year recurrence-free survival was 54% (95% CI=35.4-70.8%) and only 8% (95% CI=1.2-41.3%), respectively. Consequently, recurrence-free survival for those with tumor stages I and II as well as for those who had undergone surgery was significantly higher than for those with stages III and IV (p=0.015) and for patients who had not (p=0.0005).

OS analysis was performed, categorizing the tumor stages into early (stages I and II, n=15) and advanced (stages III and IV, n=25), as well as differentiating between resected (surgery was performed, n=28) and unresected (no surgery was performed, n=12) findings. After a follow-up of up to 24.3 years, the median survival of patients with tumor stage I or II was 19.3 years and only 4.6 years for patients suffering from tumor stage III or IV. The median survival of patients who had undergone surgery was 14 years. On the other hand, in patients who had not undergone surgical treatment, the median survival was only 1.8 years. The 5-year survival for those with early tumor stages was 86.7% (95% CI=59.5-96.6%) and 26.7% (95% CI=12.8-47.4%) for those with advanced stages. Patients who underwent surgical therapy had a 5-year survival of 64% (95% CI=45.4-79.6%), those with unresected tumors only 12.5% (95% CI=2.0-49.8%). The survival analysis is illustrated in Figure 1. Of the 25 patients diagnosed with OSCC stage III or IV, three received surgical treatment, as did 11 out of the 15 patients diagnosed with stage I or II cancer.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Kaplan–Meier estimates for recurrence-free (A) and overall (B) survival in relation to the tumor stage (left), and surgical approach (right).

The proportion of smokers was similar in both groups, with 82.5% (n=32) smokers in the case group and 72.5% (n=29) in the control group, but the percentage of heavy smokers in the case group, on the other hand, exceeded those found in the control group. No ‘light’ smokers were found among the patients with OSCC. Only two of the smokers (6%) quit after their initial cancer diagnosis; 15% (n=6) of the patients with OSCC already suffered from chronic obstructive pulmonary disease (COPD), all of whom were categorized as ‘heavy’ smokers In the case and control groups, a correlation between level of occupational status and smoking status was found: The higher the socioeconomic status, the less likely the patients were to smoke heavily or at all, and vice versa. Professional exposure to harmful substances was not identified as an influential factor.

The proportion of patients who consumed alcohol was almost equally high, with 90% in the case group versus 92.5% in the control group. The overwhelming majority (62.5%) of alcohol-consuming patients in the case group were ‘daily drinkers,’ whereas only one patient (2.5%) in the control group showed the same behavior. The majority of patients in the control group (90%) were ‘moderately frequent’ consumers. Furthermore, the frequent consumption of liquor was significantly higher in the case group (25%) compared with the control group (none), in which only 5% stated drinking beverages with high alcohol content occasionally. Independently of the alcohol content, patients with OSCC consumed alcohol significantly more frequently than their controls; 40% of the cases were categorized as alcoholics in contrast to those in the control group, in which none were diagnosed as such. Similarly, 32.5% of the cases suffered from liver disease (none in the control group); 76.9% of those with liver disease had hepatic steatosis, whereas the remainder suffered from liver cirrhosis. Both diseases coincided with heavy consumption of beverages with high alcohol content.

Combined smoking and frequent alcohol consumption was observed in 60% of the cases but only in 2.5% of the controls. Furthermore, 50% of the frequent drinkers in the case group were also heavy smokers. Most of the patients in the control group ‘occasionally’ combined drinking and smoking. Further potential risk factors including allergies, cardiovascular diseases, immunodeficiency, drug abuse, and poor oral hygiene were not found to lead to statistically significant differences between the case and control groups.

Discussion

Despite the increasing focus on HNSCC in younger adults and reports about growing prevalence in this specific patient cohort, OSCC in young patients is still a rare disease. This is especially the case when differentiating among the various subtypes of the heterogeneous group of head and neck cancers, which originate from different anatomical areas and tissues (14, 34). When trying to evaluate specific risk factors, this must be considered to avoid flawed conclusions for the sake of higher sample sizes. In our study, we focused only on OSCC, and even at a high-volume hospital, the sample size of cases with OSCC under the age of 46 years did not exceed 40 patients in a 13-year period. Nevertheless, the findings were remarkably striking.

In the overwhelming majority of studies conducted in the past years, the authors concluded that traditional risk factors played a decreasing role in younger patients suffering from OSCC, and several authors stated that females were more frequently affected in this age group (15, 16, 27, 35, 36). However, these claims have been challenged in more recent studies (22, 23). Furthermore, the literature indicates that in younger patients, the ratio of males to females is approximately 1:1 (23). In contrast, the gender distribution in our study showed a ratio of 3:1 (75% males and 25% females), which represents the traditional pattern (14).

The majority of patients in our study were of normal weight in both groups. However, the case group presented a higher number of malnourished or obese patients, which presumably results from lifestyle differences, such as frequent heavy smoking and drinking habits. High alcohol consumption was shown to be associated with higher BMI values, and the affected individuals presented a tendency toward poor diet and smoking (37, 38). In advanced cases, on the other hand, malnourishment and low BMI pose a serious threat to overall health and can have negative effects on tumor therapy (39, 40). Tobacco smoking can be associated with low socioeconomic status and higher BMI but also coincided with lower BMI in other studies (41-43). A poor diet, low in fruit and vegetables, has been correlated with oral cancer, and it has been shown that a Mediterranean diet favorably affects the risk of upper aerodigestive tract cancer (44, 45). Considering the significantly higher number of cases with pathological BMI in our young patients with cancer, nutrition might be an influential factor. Unfortunately, the retrospective setting of this study did not deliver sufficient data to substantiate this.

The tongue and the floor of the mouth were the most frequently affected sites in this study. This does not directly correspond to claims of a trend toward higher incidence of SCC of the tongue (36, 46, 47). Some data hints that in the younger population, tongue carcinoma of the lateral border accounts for more than 70% of OSCC but is quite rare in older patients (26%) (48). In this study, these cases accounted only for 32.5% of OSCC in patients under the age of 46 years. To the best of our knowledge, no study has been able to find relevant risk factors correlated with this proclaimed predominance of OSCC in the tongue (27, 48). Immunodeficiency, exposure to other pollutants, and drug abuse have been described as possible risk factors (3, 44, 48). None of these factors had a measurable impact in our study, but we cannot rule out that this might be due to the limited number of cases. In addition, p16 positivity was only found in one of the cases, and in contrast to oropharyngeal squamous cell carcinoma (OPSCC), its role in OSCC remains unclear since HPV-DNA positivity does not necessarily play a tumor-promoting role; nor does it represent a highly reliable diagnostic tool (8, 34, 49, 50).

As previously stated, the documented rise in OSCC in younger adults is repeatedly mentioned with the decline of traditional risk factors such as tobacco smoking and alcohol consumption. While the moderate consumption of alcohol and tobacco was present in both the case and control groups, the excessive abuse of both substances was primarily found in the former. The number of heavy smokers was four times higher in the case group compared with their controls (81.8% vs. 20.7%, respectively; p<0.001). Furthermore, female smokers in the case group did not rank behind their male smoking counterparts, with a percentage of heavy female smokers of 86%. This stands in stark contrast to the previously cited literature, especially since none of the female smokers in the control group could be categorized as such. After initial diagnosis, 77.5% of the patients with OSCC continued smoking, which indicates reduced disease awareness and mirrors the proportion of low-level education or socioeconomic status, which is correlated with smoking status. Even more striking is the fact that 15% of the cases (n=6) also suffered from COPD, further emphasizing excessive tobacco consumption, which is generally accepted as the primary risk factor for COPD (51, 52). Particularly because all of the COPD cases were ‘heavy’ smokers, we suggest that this results from smoking-related accelerated lung aging since the mean age of high prevalence is generally much higher (53, 54). In contrast, none of the controls suffered from secondary pulmonary damage because of moderate tobacco consumption. Therefore, secondary COPD caused by heavy smoking can also be seen as a risk indicator for OSCC in young patients.

Analogously, the frequent consumption of beverages with high alcohol content, such as liquor, in the case group exceeded that of the control group by far. The difference of frequent (daily) drinkers between cases (62.5%; n=25) and controls (2.5%, n=1) was statistically significant (p<0.001). This is correlated with the very high proportion of alcoholism among the cases of 40% (n=16). In addition, 25% of the cases stated that they consumed high-proof alcohol on a daily basis, whereas none of the controls declared likewise (p<0.001). Moreover, 32.5% (n=15, Table I) of the patients in the case group suffered from alcohol-associated liver comorbidities; 80% (n=12) statosis hepatis vs. 20% (n=3) liver cirrhosis, both associated with alcohol consumption. In contrast, only one patient in the control group was affected. This statistically significant difference (p=0.003) leads us to conclude that secondary liver disease might also serve as a risk indicator for OSCC in younger patients.

Alcohol consumption in Germany is high and especially critical in children and adolescents. A recent press release of the German Federal Statistical Office stated that the number of hospital admissions caused by alcohol intoxication in children and adolescents between 10 and 17 years has more than doubled since 2000 (55). Furthermore, the German Cancer Research Center stated in 2017 that 18% of the male and 14% of the female population consumed critical quantities of alcohol (56). Taking this into account, we must state that the percentage of cases with alcoholism in our group of young patients with OSCC is more than twice as high. Earlier and heavier alcohol abuse in adolescents and even children might nonetheless be a relevant factor. This might shorten the necessary period of exposure for tumor development in a growing body, especially when combined with other carcinogens, such as tobacco, e.g. in the form of frequent passive smoking (20, 27, 48).

In particular, the combination of alcohol and tobacco is known to have potentiating effects on carcinogenesis (2, 8, 57). Our results reflect this long-known observation; in the case group, 60% of the smokers consumed alcohol frequently (n=24), whereas only 2.5% (n=1) of the controls had the same heavy consumer behavior (p<0.001). Furthermore, 65% (n=26) of the patients with OSCC also smoked more than 20 cigarettes per day, in contrast to only 15% (n=6; odds ratio =5.958, 95% CI=1.670-21.254) in the control group. While general smoking and drinking habits were present in both groups, the case group showed predominantly abusive consumer behavior. A frequent argument against traditional risk factors in young patients is the lack of time for exposure. Upon reviewing the demonstrated results, this might not be the case if the intensity is high enough or similar doses are consumed in a shorter period.

Despite good accessibility to the oral cavity and the exclusion of oropharyngeal OPSCC, OSCC is frequently diagnosed in advanced stages mostly because of patient ignorance, as well as initial misdiagnosis (8, 58). Our findings reflect this general problem, which is all the more important since OS analysis over a period of up to almost 25 years as well as recurrence-free survival demonstrated unfavorable outcomes of advanced stages and especially devastating results of tumors that were not treated surgically. The high rate of delayed diagnosis (stage IV) is even greater than that described in the current literature and demonstrates a lack of early cancer detection in the younger population (59). In part, this might be because the general risk for OSCC might be underestimated by patients and healthcare professionals. This underlines the importance of early diagnosis and decisive surgical treatment since the outcome in patients who did not undergo surgery was tantamount to a death sentence in our patient cohort.

We conclude that the role of traditional risk factors should not be underestimated in young adults with OSCC. The abusive consumption of harmful substances might especially be a potent accelerator for carcinogenesis. In contrast to most studies, our results lead to the conclusion that secondary organ damage such as COPD and liver cirrhosis or alcohol-induced steatohepatitis can also be considered risk indicators for OSCC in the younger patient population. The influence of other risk factors cannot be evaluated sufficiently given the limited sample size. Therefore, larger prospective multicenter studies that respect the different HNSCC subtypes must be conducted to specify these findings and shed light on still-unanswered questions. Long-term survival analysis over a period of up to 25 years underlined the unfavorable outcome of advanced cancer, especially for patients who had not undergone surgical treatment. Accordingly, these findings call for routine oral cancer screening in younger patients with high-risk behavior and, in particular, secondary organ damage. Furthermore, the discrepancy between the relatively short recurrence-free survival and OS demonstrates the importance of close aftercare and follow-up for recurrence.

Footnotes

  • Authors’ Contributions

    Conceptualization: J.R., N.N. and C.D. Data collection and curation: M.M., N.N., D.T., J.W. and S.K. Data analysis and interpretation: K.N., N.N., K.J. and C.D. Resources and supervision: J.R., M.H. and K.J. Writing the original article: N.N. Editing: N.N., J.W., S.K. and D.T. All Authors revised the final article and approved its publication.

  • Conflicts of Interest

    The Authors have no conflicts of interest to declare in relation to this study.

  • Received October 11, 2020.
  • Revision received October 25, 2020.
  • Accepted October 27, 2020.
  • Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

References

  1. 1.↵
    1. Ragin CC,
    2. Modugno F and
    3. Gollin SM
    : The epidemiology and risk factors of head and neck cancer: A focus on human papillomavirus. J Dent Res 86(2): 104-114, 2007. PMID: 17251508. DOI:10.1177/154405910708600202
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Franceschi S,
    2. Levi F,
    3. La Vecchia C,
    4. Conti E,
    5. Dal Maso L,
    6. Barzan L and
    7. Talamini R
    : Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int J Cancer 83(1): 1-4, 1999. PMID: 10449598. DOI: 10.1002/(sici)1097-0215(19990924)83:1<1::aid-ijc1>3.0.co;2-8
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Liu X,
    2. Gao XL,
    3. Liang XH and
    4. Tang YL
    : The etiologic spectrum of head and neck squamous cell carcinoma in young patients. Oncotarget 7(40): 66226-66238, 2016. PMID: 27528225. DOI:10.18632/oncotarget.11265
    OpenUrl
  4. 4.↵
    1. Syrjänen S,
    2. Rautava J and
    3. Syrjänen K
    : HPV in head and neck cancer – 30 years of history. Recent Results Cancer Res 206: 3-25, 2017. PMID: 27699526. DOI:10.1007/978-3-319-43580-0_1
    OpenUrl
  5. 5.↵
    1. Hanahan D and
    2. Weinberg Robert A
    : Hallmarks of cancer: The next generation. Cell 144(5): 646-674, 2011. PMID: 21376230. DOI: 10.1016/j.cell.2011.02.013
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Leemans CR,
    2. Braakhuis BJ and
    3. Brakenhoff RH
    : The molecular biology of head and neck cancer. Nat Rev Cancer 11(1): 9-22, 2011. PMID: 21160525. DOI: 10.1038/nrc2982
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Pai SI and
    2. Westra WH
    : Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 4: 49-70, 2009. PMID: 18729723. DOI: 10.1146/annurev.pathol.4.110807.092158
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Rivera C
    : Essentials of oral cancer. Int J Clin Exp Pathol 8(9): 11884-11894, 2015. PMID: 26617944. Oral Oncol 45(9): e85-89, 2009. PMID: 19457708. DOI: 10.1016/j.oraloncology.2009.03.010
    OpenUrlCrossRefPubMed
  9. 10.
    1. Annertz K,
    2. Anderson H,
    3. Biorklund A,
    4. Moller T,
    5. Kantola S,
    6. Mork J,
    7. Olsen JH and
    8. Wennerberg J
    : Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 101(1): 95-99, 2002. PMID: 12209594. DOI: 10.1002/ijc.10577
    OpenUrlCrossRefPubMed
  10. 11.↵
    1. Macfarlane GJ,
    2. Boyle P and
    3. Scully C
    : Oral cancer in Scotland: Changing incidence and mortality. BMJ 305(6862): 1121-1123, 1992. PMID: 1463946. DOI: 10.1136/bmj.305.6862.1121
    OpenUrlAbstract/FREE Full Text
  11. 12.↵
    1. Majchrzak E,
    2. Szybiak B,
    3. Wegner A,
    4. Pienkowski P,
    5. Pazdrowski J,
    6. Luczewski L,
    7. Sowka M,
    8. Golusinski P,
    9. Malicki J and
    10. Golusinski W
    : Oral cavity and oropharyngeal squamous cell carcinoma in young adults: A review of the literature. Radiol Oncol 48(1): 1-10, 2014. PMID: 24587773. DOI: 10.2478/raon-2013-0057
    OpenUrlCrossRefPubMed
  12. 13.
    1. Callinan JE,
    2. Clarke A,
    3. Doherty K and
    4. Kelleher C
    : Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev 4(4), 2010. DOI: 10.1002/14651858.CD005992.pub2
    OpenUrlCrossRef
  13. 14.↵
    1. van Monsjou HS,
    2. Wreesmann VB,
    3. van den Brekel MW and
    4. Balm AJ
    : Head and neck squamous cell carcinoma in young patients. Oral Oncol 49(12): 1097-1102, 2013. PMID: 24103389. DOI: 10.1016/j.oraloncology.2013.09.001
    OpenUrlCrossRef
  14. 15.↵
    1. Myers JN,
    2. Elkins T,
    3. Roberts D and
    4. Byers RM
    : Squamous cell carcinoma of the tongue in young adults: Increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122(1): 44-51, 2000. PMID: 10629481. DOI: 10.1016/S0194-5998(00)70142-2
    OpenUrlCrossRefPubMed
  15. 16.↵
    1. Harris SL,
    2. Kimple RJ,
    3. Hayes DN,
    4. Couch ME and
    5. Rosenman JG
    : Never-smokers, never-drinkers: Unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck 32(4): 499-503, 2010. PMID: 19691028. DOI: 10.1002/hed.21220
    OpenUrlCrossRefPubMed
  16. 17.↵
    1. Byers RM
    : Squamous cell carcinoma of the oral tongue in patients less than thirty years of age. Am J Surg 130(4): 475-478, 1975. PMID: 1166939. DOI:10.1016/0002-9610(75)90487-0
    OpenUrlCrossRefPubMed
  17. 18.↵
    1. Kuriakose M,
    2. Sankaranarayanan M,
    3. Nair MK,
    4. Cherian T,
    5. Sugar AW,
    6. Scully C and
    7. Prime SS
    : Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol 28b(2): 113-120, 1992. PMID: 1306728. DOI: 10.1016/0964-1955(92)90038-3
    OpenUrlCrossRef
  18. 19.↵
    1. Muller S,
    2. Pan Y,
    3. Li R and
    4. Chi AC
    : Changing trends in oral squamous cell carcinoma with particular reference to young patients: 1971-2006. The Emory University experience. Head Neck Pathol 2(2): 60-66, 2008. PMID: 20614324. DOI: 10.1007/s12105-008-0054-5
    OpenUrlCrossRefPubMed
  19. 20.↵
    1. Llewellyn CD,
    2. Johnson NW and
    3. Warnakulasuriya KA
    : Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: A case–control study in Southern England. J Oral Pathol Med 33(9): 525-532, 2004. PMID: 15357672. DOI: 10.1111/j.1600-0714.2004.00222.x
    OpenUrlCrossRefPubMed
  20. 21.↵
    1. Doll C,
    2. Arsenic R,
    3. Lage H,
    4. Johrens K,
    5. Hartwig S,
    6. Nelson K and
    7. Raguse JD
    : Expression of estrogen receptors in OSCC in relation to histopathological grade. Anticancer Res 35(11): 5867-5872, 2015. PMID: 26504009.
    OpenUrlAbstract/FREE Full Text
  21. 22.↵
    1. Santos HB,
    2. dos Santos TK,
    3. Paz AR,
    4. Cavalcanti YW,
    5. Nonaka CF,
    6. Godoy GP and
    7. Alves PM
    : Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis. Med Oral Patol Oral Cir Bucal 21(2): e151-156, 2016. PMID: 26827057. DOI: 10.4317/medoral.20770
    OpenUrlCrossRef
  22. 23.↵
    1. de Morais EF,
    2. Mafra RP,
    3. Gonzaga AKG,
    4. de Souza DLB,
    5. Pinto LP and
    6. da Silveira ÉJD
    : Prognostic factors of oral squamous cell carcinoma in young patients: A systematic review. J Oral Maxillofac Surg 75(7): 1555-1566, 2017. PMID: 28061358. DOI: 10.1016/j.joms.2016.12.017
    OpenUrlCrossRef
  23. 24.↵
    1. Ferreira S,
    2. Peter C,
    3. Ricardo AB,
    4. Gomez S,
    5. Rodrigues E,
    6. Alan F,
    7. Manoela RS-s, Martins D,
    8. Siavash GDC-j and
    9. Fonseca P
    : Molecular basis of oral squamous cell carcinoma in young patients: Is it any different from older patients? J Oral Pathol Med 47(6): 541-546, 2017. PMID: 28922483. DOI: 10.1111/jop.12642
    OpenUrlCrossRef
  24. 25.↵
    1. Naz S,
    2. Salah K,
    3. Khurshid A,
    4. Hashmi AA and
    5. Faridi N
    : Head and neck squamous cell carcinoma – Comparative evaluation of pathological parameters in young and old patients. Asian Pac J Cancer Prev 16(9): 4061-4063, 2015. PMID: 25987087. DOI: 10.7314/apjcp.2015.16.9.4061
    OpenUrlCrossRef
  25. 26.↵
    1. Cardesa A and
    2. Nadal A
    : Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol Alp Pannonica Adriat 20(3): 161-173, 2011. PMID: 22131117.
    OpenUrlPubMed
  26. 27.↵
    1. Mohideen K,
    2. Krithika C,
    3. Jeddy N,
    4. Bharathi R,
    5. Thayumanavan B and
    6. Sankari SL
    : Meta-analysis on risk factors of squamous cell carcinoma of the tongue in young adults. J Oral Maxillofac Pathol 23(3): 450-457, 2019. PMID: 31942130. DOI: 10.4103/jomfp.JOMFP_118_19
    OpenUrlCrossRef
  27. 28.↵
    1. Chaturvedi AK,
    2. Engels EA,
    3. Anderson WF and
    4. Gillison ML
    : Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26(4): 612-619, 2008. PMID: 18235120. DOI: 10.1200/JCO.2007.14.1713
    OpenUrlAbstract/FREE Full Text
  28. 29.↵
    1. Guo G,
    2. Schwedtner O and
    3. Klein M
    : A retrospective study of implant-retained auricular prostheses. Int J Oral Maxillofac Implants 23(3): 539-543, 2008. PMID: 18700380.
    OpenUrlPubMed
  29. 30.↵
    1. Hermanek P,
    2. Hutter RVP,
    3. Sobin LH,
    4. Wagner G and
    5. Wittekind Ch
    (eds.): TNM Atlas Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. Union for International Cancer Control. Springer-Verlag, Berlin, 1997.
  30. 31.↵
    1. Schulze A and
    2. Lampert T
    : Bundes-gesundheitssurvey: Soziale Unterschiede im Rauchverhalten und in der Passivrauchbelastung in Deutschland. Berlin, Robert Koch-Institut. 2006. Available at https://edoc.rki.de/bitstream/handle/176904/3212/27ocvYbxUG4w_10.pdf?sequence=1 [Last accessed on October 27th, 2020]
  31. 32.↵
    1. Baker SP,
    2. Braver ER,
    3. Chen LH,
    4. Li G and
    5. Williams AF
    : Drinking histories of fatally injured drivers. Inj Prev 8(3): 221-226, 2002. PMID: 12226120. DOI: 10.1136/ip.8.3.221
    OpenUrlAbstract/FREE Full Text
  32. 33.↵
    1. World Health Organization
    : International Guide for Monitoring Alcohol Consumption and Related Harm (No. WHO/MSD/MSB/00.4). Geneva, World Health Organization, 2000. Available at https://apps.who.int/iris/bitstream/handle/10665/66529/WHO_MSD_MSB_00.4.pdf [Last accessed on October 27th, 2020]
  33. 34.↵
    1. Cramer JD,
    2. Burtness B,
    3. Le QT and
    4. Ferris RL
    : The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol 16(11): 669-683, 2019. PMID: 31189965. DOI: 10.1038/s41571-019-0227-z
    OpenUrlCrossRefPubMed
  34. 35.↵
    1. Fang QG,
    2. Shi S,
    3. Liu FY and
    4. Sun CF
    : Tongue squamous cell carcinoma as a possible distinct entity in patients under 40 years old. Oncol Lett 7(6): 2099-2102, 2014. PMID: 24932296. DOI: 10.3892/ol.2014.2054
    OpenUrlCrossRefPubMed
  35. 36.↵
    1. Troeltzsch M,
    2. Knosel T,
    3. Eichinger C,
    4. Probst F,
    5. Troeltzsch M,
    6. Woodlock T,
    7. Mast G,
    8. Ehrenfeld M and
    9. Otto S
    : Clinicopathologic features of oral squamous cell carcinoma: Do they vary in different age groups? J Oral Maxillofac Surg 72(7): 1291-1300, 2014. PMID: 24813775. DOI: 10.1016/j.joms.2014.01.009
    OpenUrlCrossRefPubMed
  36. 37.↵
    1. Xie YD,
    2. Zhao CQ,
    3. Wang JP,
    4. Cheng CS,
    5. Zhou JY,
    6. Zhang Y,
    7. Xia H and
    8. Wei L
    : Alcohol consumption analysis among patients with liver disease in China. Chin Med J 132(4): 420-430, 2019. PMID: 30707167. DOI: 10.1097/CM9.0000000000000067
    OpenUrlCrossRef
  37. 38.↵
    1. Bellis MA,
    2. Hughes K,
    3. Nicholls J,
    4. Sheron N,
    5. Gilmore I and
    6. Jones L
    : The alcohol harm paradox: Using a national survey to explore how alcohol may disproportionately impact health in deprived individuals. BMC Public Health 16: 111, 2016. PMID: 26888538. DOI: 10.1186/s12889-016-2766-x
    OpenUrlCrossRefPubMed
  38. 39.↵
    1. Anand AC
    : Nutrition and muscle in cirrhosis. J Clin Exp Hepatol 7(4): 340-357, 2017. PMID: 29234200. DOI: 10.1016/j.jceh.2017.11.001
    OpenUrlCrossRef
  39. 40.↵
    1. Grossberg AJ,
    2. Chamchod S,
    3. Fuller CD,
    4. Mohamed AS,
    5. Heukelom J,
    6. Eichelberger H,
    7. Kantor ME,
    8. Hutcheson KA,
    9. Gunn GB,
    10. Garden AS,
    11. Frank S,
    12. Phan J,
    13. Beadle B,
    14. Skinner HD,
    15. Morrison WH and
    16. Rosenthal DI
    : Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol 2(6): 782-789, 2016. PMID: 26891703. DOI: 10.1001/jamaoncol.2015.6339
    OpenUrlCrossRef
  40. 41.↵
    1. Wandycz A,
    2. Jankowiak L and
    3. Jerzak I
    : Prevalence of smoking and BMI differences between smokers and non-smokers among children and adolescents aged 7-18 years in South-east Poland. Anthropol Anz 75(2): 101-111, 2018. PMID: 29542800. DOI: 10.1127/anthranz/2018/0782
    OpenUrlCrossRef
  41. 42.
    1. Schindler-Ruwisch J,
    2. Augustson E,
    3. Lynch K and
    4. Patrick H
    : BMI and smoking: Interrelated factors among cessation website users. Am J Health Behav 39(3): 330-337, 2015. PMID: 25898436. DOI: 10.5993/AJHB.39.3.5
    OpenUrlCrossRef
  42. 43.↵
    1. Piirtola M,
    2. Jelenkovic A,
    3. Latvala A,
    4. Sund R,
    5. Honda C,
    6. Inui F,
    7. Watanabe M,
    8. Tomizawa R,
    9. Iwatani Y,
    10. Ordonana JR,
    11. Sanchez-Romera JF,
    12. Colodro-Conde L,
    13. Tarnoki AD,
    14. Tarnoki DL,
    15. Martin NG,
    16. Montgomery GW,
    17. Medland SE,
    18. Rasmussen F,
    19. Tynelius P,
    20. Tan Q,
    21. Zhang D,
    22. Pang Z,
    23. Rebato E,
    24. Stazi MA,
    25. Fagnani C,
    26. Brescianini S,
    27. Busjahn A,
    28. Harris JR,
    29. Brandt I,
    30. Nilsen TS,
    31. Cutler TL,
    32. Hopper JL,
    33. Corley RP,
    34. Huibregtse BM,
    35. Sung J,
    36. Kim J,
    37. Lee J,
    38. Lee S,
    39. Gatz M,
    40. Butler DA,
    41. Franz CE,
    42. Kremen WS,
    43. Lyons MJ,
    44. Magnusson PKE,
    45. Pedersen NL,
    46. Dahl Aslan AK,
    47. Oncel SY,
    48. Aliev F,
    49. Derom CA,
    50. Vlietinck RF,
    51. Loos RJF,
    52. Silberg JL,
    53. Maes HH,
    54. Boomsma DI,
    55. Sorensen TIA,
    56. Korhonen T,
    57. Kaprio J and
    58. Silventoinen K
    : Association of current and former smoking with body mass index: A study of smoking discordant twin pairs from 21 twin cohorts. Plos One 13(7): e0200140, 2018. PMID: 30001359. DOI: 10.1371/journal.pone.0200140
    OpenUrlCrossRef
  43. 44.↵
    1. Llewellyn CD,
    2. Johnson NW and
    3. Warnakulasuriya KA
    : Risk factors for squamous cell carcinoma of the oral cavity in young people – A comprehensive literature review. Oral Oncol 37(5): 401-418, 2001. PMID: 11377229. DOI: 10.1016/s1368-8375(00)00135-4
    OpenUrlCrossRefPubMed
  44. 45.↵
    1. Bosetti C,
    2. Gallus S,
    3. Trichopoulou A,
    4. Talamini R,
    5. Franceschi S,
    6. Negri E and
    7. La Vecchia C
    : Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 12(10): 1091-1094, 2003. PMID: 14578148.
    OpenUrlAbstract/FREE Full Text
  45. 46.↵
    1. Toner M and
    2. O’Regan EM
    : Head and neck squamous cell carcinoma in the young: A spectrum or a distinct group? Part 1. Head Neck Pathol 3(3): 246-248, 2009. PMID: 20596979. DOI: 10.1007/s12105-009-0135-0
    OpenUrlCrossRefPubMed
  46. 47.↵
    1. Ho HC,
    2. Lee MS,
    3. Hsiao SH,
    4. Hwang JH,
    5. Hung SK,
    6. Chou P and
    7. Lee CC
    : Squamous cell carcinoma of the oral cavity in young patients: A matched-pair analysis. Eur Arch Otorhinolaryngol 265(Suppl 1): S57-61, 2008. PMID: 17957378. DOI: 10.1007/s00405-007-0496-5
    OpenUrlCrossRefPubMed
  47. 48.↵
    1. Hirota SK,
    2. Braga FP,
    3. Penha SS,
    4. Sugaya NN and
    5. Migliari DA
    : Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: A comparative analysis. Medicina Oral Patologia Oral y Cirugia Bucal 13(4): 227, 2008. PMID: 18379445.
    OpenUrl
  48. 49.↵
    1. Hübbers CU and
    2. Akgül B
    : HPV and cancer of the oral cavity. Virulence 6(3): 244-248, 2015. PMID: 25654476. DOI: 10.1080/21505594.2014.999570
    OpenUrlCrossRef
  49. 50.↵
    1. Götz C,
    2. Drecoll E,
    3. Straub M,
    4. Bissinger O,
    5. Wolff KD and
    6. Kolk A
    : Impact of HPV infection on oral squamous cell carcinoma. Oncotarget 7(47): 76704-76712, 2016. PMID: 27732948. DOI: 10.18632/oncotarget.12501
    OpenUrlCrossRef
  50. 51.↵
    1. Salvi S
    : Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin Chest Med 35(1): 17-27, 2014. PMID: 24507834. DOI: 10.1016/j.ccm.2013.09.011
    OpenUrlCrossRefPubMed
  51. 52.↵
    1. Onishi K
    : Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol 70(2): 128-134, 2017. PMID: 28325523. DOI: 10.1016/j.jjcc.2017.03.001
    OpenUrlCrossRef
  52. 53.↵
    1. McCarthy B,
    2. Casey D,
    3. Devane D,
    4. Murphy K,
    5. Murphy E and
    6. Lacasse Y
    : Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2: Cd003793, 2015. PMID: 25705944. DOI: 10.1002/14651858.CD003793.pub3
    OpenUrlCrossRef
  53. 54.↵
    1. Ntritsos G,
    2. Franek J,
    3. Belbasis L,
    4. Christou MA,
    5. Markozannes G,
    6. Altman P,
    7. Fogel R,
    8. Sayre T,
    9. Ntzani EE and
    10. Evangelou E
    : Gender-specific estimates of COPD prevalence: A systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 13: 1507-1514, 2018. PMID: 29785100. DOI: 10.2147/COPD.S146390
    OpenUrlCrossRefPubMed
  54. 55.↵
    1. Office GFS
    : German federal statistical office: Press release February 20, 2020. Available at: https://www.Destatis.De/de/presse/pressemitteilungen/zahl-der-woche/2020/pd20_08_p002.Html.
  55. 56.↵
    1. Schaller K and
    2. Kahnert S
    : Alkoholatlas Deutschland 2017. Pabst Science Publishers, 2017.
  56. 57.↵
    1. Bagnardi V,
    2. Blangiardo M,
    3. La Vecchia C and
    4. Corrao G
    : Alcohol consumption and the risk of cancer: A meta-analysis. Alcohol Res Health 25(4): 263-270, 2001. PMID: 11910703.
    OpenUrlPubMed
  57. 58.↵
    1. Markopoulos AK
    : Current aspects on oral squamous cell carcinoma. Open Dent J 6: 126-130, 2012. PMID: 22930665. DOI: 10.2174/1874210601206010126
    OpenUrlCrossRefPubMed
  58. 59.↵
    1. Grunwald V,
    2. Chirovsky D,
    3. Cheung WY,
    4. Bertolini F,
    5. Ahn MJ,
    6. Yang MH,
    7. Castro G,
    8. Berrocal A,
    9. Sjoquist K,
    10. Kuyas H,
    11. Auclair V,
    12. Guillaume X,
    13. Joo S,
    14. Shah R and
    15. Harrington K
    : Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the glance H&N study. Oral Oncol 102: 104526, 2020. PMID: 31978755. DOI: 10.1016/j.oraloncology.2019.104526
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Anticancer Research: 40 (12)
Anticancer Research
Vol. 40, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma
NORBERT NECKEL, MARCO MICHAEL, DANIEL TROELTZSCH, JONAS WÜSTER, STEFFEN KOERDT, CHRISTIAN DOLL, KORINNA JÖHRENS, KONRAD NEUMANN, MAX HEILAND, JAN-DIRK RAGUSE
Anticancer Research Dec 2020, 40 (12) 6987-6995; DOI: 10.21873/anticanres.14723

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma
NORBERT NECKEL, MARCO MICHAEL, DANIEL TROELTZSCH, JONAS WÜSTER, STEFFEN KOERDT, CHRISTIAN DOLL, KORINNA JÖHRENS, KONRAD NEUMANN, MAX HEILAND, JAN-DIRK RAGUSE
Anticancer Research Dec 2020, 40 (12) 6987-6995; DOI: 10.21873/anticanres.14723
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Keywords

  • oral squamous cell carcinoma
  • OSCC
  • risk factors
  • young adults
  • case-control study
  • survival analysis
  • smoking
  • alcohol consumption
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire